Our findings indicate that dual-target CAR-NK cells can simultaneously target CD20 and/or CD19 antigens in ALL, exhibiting significantly higher cytotoxicity compared to CD19 CAR-NK or CD20 CAR-NK cells. Here, CD19 is linked to acute lymphoblastic leukemia.